Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Michael J. Bohn"'
Publikováno v:
Journal of Substance Abuse Treatment. 36:1-6
A post hoc analysis examined the effect of extended-release naltrexone (XR-NTX) treatment combined with psychosocial support on alcohol consumption during holiday and nonholiday periods in a cohort of alcohol-dependent patients who had maintained at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83cc3c0cc73e7005400dc2945979c6e8
https://doi.org/10.1016/j.jsat.2008.07.001
https://doi.org/10.1016/j.jsat.2008.07.001
Publikováno v:
American Journal on Addictions. 14:248-255
Urges for alcohol can lead to relapse, but some alcoholics report few urges. We hypothesized that ecological momentary assessment techniques would reveal multiple urge patterns in newly-abstinent alcoholics. Forty-eight alcohol-dependent subjects use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bef3a7551c41ab8ba3112147f0cd7d4
https://doi.org/10.1080/10550490590949424
https://doi.org/10.1080/10550490590949424
Autor:
Helen M. Pettinati, Gantt P. Galloway, Sakari Karhuvaara, Michael J. Bohn, Henry R. Kranzler, Raymond F. Anton, Allen Zweben, Mary E. McCaul, James C. Garbutt, David R. Gastfriend, Robert M. Anthenelli, Bankole A. Johnson, Ihsan M. Salloum, Robert M. Swift, Antero Kallio
Publikováno v:
Journal of Clinical Psychopharmacology. 24:421-428
The opiate antagonist nalmefene has been shown in 2 single-site studies to reduce alcohol consumption and relapse drinking in alcohol-dependent individuals. This safety and preliminary multisite efficacy study evaluated 3 doses of nalmefene (5, 20, o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76444205834dc051164784424e21babb
https://doi.org/10.1097/01.jcp.0000130555.63254.73
https://doi.org/10.1097/01.jcp.0000130555.63254.73
Autor:
Nancy M. Petry, Michael J. Bohn
Publikováno v:
Science & Practice Perspectives
Contingency management approaches that reward patients for meeting their drug abuse treatment objectives have demonstrated effectiveness in cocaine dependence clinical trials nationwide. The cost of such programs, however, was considered prohibitive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18096dba33028d5ce4a722fb480c6d2a
https://doi.org/10.1151/spp032155
https://doi.org/10.1151/spp032155
Publikováno v:
Alcoholism: Clinical and Experimental Research. 26:207-211
Background: Interactive voice response (IVR) technology integrates touch-tone telephones with computer-automated data processing. IVR offers a convenient, efficient method for remote collection of self-report data. Methods: Twenty-six subjects recrui
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc4f117e4e1812f0f5576760e4be75eb
https://doi.org/10.1111/j.1530-0277.2002.tb02525.x
https://doi.org/10.1111/j.1530-0277.2002.tb02525.x
Publikováno v:
Addictive Behaviors. 22:431-436
Naltrexone is approved for daily use in the treatment of alcohol dependence. We evaluated the feasibility of using targeted naltrexone (i.e., on an “as-needed” basis) to treat early problem drinkers. Twenty-one subjects (52% male) received brief
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfbe6264b8794a41e1cccafe46f3f22e
https://doi.org/10.1016/s0306-4603(96)00064-0
https://doi.org/10.1016/s0306-4603(96)00064-0
Autor:
Bankole Johnson, Raymond F. Anton, Christopher Clyde, Henry R. Kranzler, Helen M. Pettinati, Robert Weinreib, Gantt P. Galloway, Barbara J. Mason, Donald R. Jasinski, Richard A. Rawson, Michael J. Bohn
Publikováno v:
Psychopharmacology. 128:206-215
Four hundred and twenty-three alcohol dependent subjects were enrolled into a 12-week randomized, double-blind, placebo-controlled study to determine the safety and efficacy of the 5-HT2 receptor antagonist, ritanserin (2.5 mg/day or 5 mg/day), in re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9855596059402d2c3f1f90d8e22d05e7
https://doi.org/10.1007/s002130050126
https://doi.org/10.1007/s002130050126
Publikováno v:
Alcoholism: Clinical and Experimental Research. 19:600-606
Although drinking urges and cravings are commonly reported by alcoholics, prospective studies have found inconsistent associations between such urges and drinking relapses. Previous studies have measured drinking urges by use of single-item ratings o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cdb9daeb1ec0e84520045da8a51c374
https://doi.org/10.1111/j.1530-0277.1995.tb01554.x
https://doi.org/10.1111/j.1530-0277.1995.tb01554.x
Autor:
N. Liebowitz, Janice M. Brown, Joseph A. Burleson, F K Del Boca, Henry R. Kranzler, Patricia Korner, Michael J. Bohn
Publikováno v:
American Journal of Psychiatry. 152:391-397
Objective: The authors tested the hypothesis that fluoxetine, when used in combination with relapse prevention psychotherapy, directly reduces relapse frequency and severity for alcoholics. method: The authors conducted a randomized, placebo-controll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e302937e8bae4de2760157853c0dfef8
https://doi.org/10.1176/ajp.152.3.391
https://doi.org/10.1176/ajp.152.3.391
Publikováno v:
The American Journal on Addictions. 3:91-99
Naltrexone (NTX) has been shown to be safe and effective in reducing relapses among alcoholics. Among nondependent heavy drinkers, who are more numerous in the general population than are alcohol-dependent drinkers, brief counseling has been shown to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9777fb6fd636702b9b75e32b6f7f150
https://doi.org/10.1111/j.1521-0391.1994.tb00375.x
https://doi.org/10.1111/j.1521-0391.1994.tb00375.x